Found 93 matching trials
Cadonilimab Plus CapeOX as First-Line Treatment for Advanced GC/GEJC With High TMEscore PHASE2 This is a single-arm, open-label, multi-center clinical study to evaluate t...
Show More Location
Nanfang Hospital, Southern Medical University
Learn More & Join Trial
A Platform Trial for Personalized and Adaptive Therapies in Hepatocellular Carcinoma PHASE2 This is a phase II, multi-arm, Bayesian adaptive platform trial designed to...
Show More Location
Zhongshan Hospital, Fudan University
Learn More & Join Trial
HAIC Combined With Lenvatinib and PD-1 Inhibitor in Infiltrative Hepatocellular Carcinoma N/A Hepatic arterial infusion chemotherapy (HAIC) plus lenvatinib and programme...
Show More Location
Chinese PLA General hospital
Learn More & Join Trial
Capecitabine Combined With Lenvatinib and Tislelizumab as Adjuvant Treatment After Resection in Patients With BTC PHASE2 This is a prospective, open-label, single-center clinical study, to evaluat...
Show More Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial
Combined HAIC, TKI/Anti-VEGF and ICIs as Conversion Therapy for Unresectable Hepatocellular Carcinoma N/A This study is conducted to evaluate the efficacy, prognosis, adverse effect...
Show More Location
The Second Affiliated Hospital of Fujian Medical University
Learn More & Join Trial
Tislelizumab+Lenvatinib+Gemox Regiment for Potentially Resectable Locally Advanced Malignant Tumors of Biliary System. PHASE2 This is a single-arm, open, Phase II clinical study of Tislelizumab combine...
Show More Location
Tianjin Medical University Cancer Institute & Hospital
Learn More & Join Trial
The Safety and Efficacy of Ondansetron in Reducing Immune Checkpoint Inhibitor-Related Toxicities PHASE2 This study is a prospective, randomized, single-center randomized controlle...
Show More Location
First Affiliated Hospital of Wenzhou Medical University
Learn More & Join Trial
Lenvatinib, Tislelizumab Combined with Gemcitabine and Cisplatin (GPLET) in the Treatment of Advanced Cholangiocarcinoma PHASE3 Cholangiocarcinoma (CCA) is a heterogeneous group of cancers arising from t...
Show More Location
The Second Affiliated Hospital, Zhejiang University School of Medicine
Learn More & Join Trial
A Randomized Controlled Trial Evaluating Different Doses of Oral Zinc Supplementation in Combination With Targeted Immunotherapy for Unresectable or Advanced Hepatocellular Carcinoma PHASE2 This study will look at whether adding daily oral zinc supplements to targe...
Show More Location
The First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital)
Learn More & Join Trial
Cryoablation Combined With Lenvatinib Plus Tislelizumab Compared With FOLFOX in Patients With Advanced Intrahepatic Cholangiocarcinoma (CASTLE-ZS-01) PHASE2 This study will evaluate the efficacy and safety of cryoablation combined w...
Show More Location
Zhongshan Hospital, Fudan University
Learn More & Join Trial